Skip to main content

Table 2 Genotype and allele frequencies between study groups

From: Novel association between FOXO3 rs2232365 polymorphism and late-onset preeclampsia: a case-control candidate genetic study

SNP ID Model Controls
N = 158 (100%)
PE EOPE LOPE
SNPs    N = 177(%) ϰ2 Pa N = 70(%) ϰ2 Pb N = 107(%) ϰ2 PC
rs2232365 CC 21(13.29%) 35(19.77%) 4.016 0.134 10(14.29%) 0.799 0.671 25(23.36%) 5.682 0.058
CT 80(50.63%) 93(52.545) 39(55.71%) 54(50.47%)
TT 57(36.08%) 49(27.68%) 21(30.00%) 28(26.17%)
Genotype TT+CT/CC 137(86.71%) 142(80.23%) 2.520 0.112 60(85.71%) 0.041 0.840 82(76.63%) 4.513 0.034
CC 21(13.29) 35(19.77%) 10(14.29%) 25(23.36%)
Allele C 122(38.61%) 163(47.25%)   0.052 59(42.14%)   0.477 104(48.60%)   0.021
T 194(61.39%) 191(55.36%)   81(57.86%)   110(51.40%)  
rs3853839 CC 10(6.33%) 15(8.47%) 3.731 0.155 7(10.00%) 0.949 0.622 8(7.48%) 6.490 0.039
CG 78(49.37%) 69(38.98%) 33(47.14%) 36(33.64%)
GG 70(44.30%) 93(52.54%) 30(42.86%) 63(58.87%)
Genotype CC+CG 88(55.70%) 84(47.46%) 2.268 0.132 40(57.14%) 0.041 0.839 44(41.12%) 5.412 0.020
GG 70(44.30%) 93(52.54%) 30(42.86%) 63(58.88%)
Allele C 98(31.01%) 99(28.70%)   0.747 47(33.57%)   0.293 52(24.30%)   0.092
G 218(68.99%) 255(73.91%)   93(66.43%)   162(75.70%)  
rs3761548 GG 88(55.70%) 87(49.15%) 1.489 0.475 33(47.14%) 1.534 0.464 54(50.47%) 0.713 0.700
GT 63(39.87%) 82(46.33%) 34(48.57%) 48(44.86%)
TT 7(4.43%) 8(4.52%) 3(4.29%) 5(4.67%)
Genotype TT+TG 88(55.70%) 87(49.15%) 1.433 0.231 33(47.14%) 1.425 0.233 54(50.47%) 0.701 0.401
GG 70(44.30%) 90(50.85%) 37(52.86%) 53(49.53%)
Allele G 239(75.63%) 256(74.20%)   0.329 100(71.43%)   0.343 156()72.90%   0.478
T 77(24.37%) 98(28.41%)   40(28.57%)   58(27.11%)  
  1. PE Represents Preeclampsia, EOPE Represents early- onset preeclampsia, LOPE Represents late-onset preeclampsia. a PE vs controls, b EOPE vs controls, c LOPE vs controls, * Pa < 0.05; * Pb and PC < 0.017 for sub-group